These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15391935)

  • 1. The potentiation of the antimalarial activity of chloroguanide by p-aminobenzoic acid competitors.
    GREENBERG J
    J Pharmacol Exp Ther; 1949 Oct; 97(2):238-42. PubMed ID: 15391935
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of the antimalarial activity of chlorguanide by pteroylglutamic acid.
    GREENBERG J
    Proc Soc Exp Biol Med; 1949 Jun; 71(2):306-8. PubMed ID: 18134046
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tolerance and efficacy of atovaquone-proguanil for the treatment of paediatric imported Plasmodium falciparum malaria in France: clinical practice in a university hospital in Paris].
    Blondé R; Naudin J; Bigirimana Z; Holvoet L; Fenneteau O; Vitoux C; Bourdon O; Angoulvant F; Lorrot M; D'Ortenzio E; Bourrillon A; Le Bras J; Matheron S; Faye A
    Arch Pediatr; 2008 Mar; 15(3):245-52. PubMed ID: 18321692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atovaquone-proguanil for prophylaxis and treatment of malaria.
    Marra F; Salzman JR; Ensom MH
    Ann Pharmacother; 2003 Sep; 37(9):1266-75. PubMed ID: 12921511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
    Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LABORATORY STUDIES ON THE REPOSITORY ANTIMALARIAL ACTIVITY OF 4,4'-DIACETYLAMINODIPHENYLSULFONE, ALONE AND MIXED WITH CYCLOGUANIL PAMOATE (CI-501).
    THOMPSON PE; OLSZEWSKI B; WAITZ JA
    Am J Trop Med Hyg; 1965 May; 14():343-53. PubMed ID: 14292737
    [No Abstract]   [Full Text] [Related]  

  • 7. Malaria prophylaxis with proguanil and sulfisoxazole in children living in a malaria endemic area.
    Pang LW; Limsomwong N; Singharaj P; Canfield CJ
    Bull World Health Organ; 1989; 67(1):51-8. PubMed ID: 2706727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modern antimalarial therapy.
    PFEIFFER CC
    Mod Hosp; 1952 Aug; 79(2):106-8. PubMed ID: 12992919
    [No Abstract]   [Full Text] [Related]  

  • 9. Trends in antimalarial prescriptions in Australia 2002 to 2005.
    Leggat PA
    J Travel Med; 2008; 15(5):302-6. PubMed ID: 19006502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Variability of in vitro activity of proguanil and cycloguanil on erythrocyte stages of Plasmodium falciparum as a function of culture conditions].
    Ndounga M; Basco LK; Ringwald P
    Bull Soc Pathol Exot; 1999 Dec; 92(5):313-6. PubMed ID: 10690466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
    Ling J; Baird JK; Fryauff DJ; Sismadi P; Bangs MJ; Lacy M; Barcus MJ; Gramzinski R; Maguire JD; Kumusumangsih M; Miller GB; Jones TR; Chulay JD; Hoffman SL;
    Clin Infect Dis; 2002 Oct; 35(7):825-33. PubMed ID: 12228819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Exacerbation of psoriasis caused by malaria prophylaxis with chloroquine and proguanil].
    Damstra RJ; van Vloten WA
    Ned Tijdschr Geneeskd; 1991 Apr; 135(15):671-3. PubMed ID: 2038384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chloroguanide metabolism in relation to the efficacy in malaria prophylaxis and the S-mephenytoin oxidation in Tanzanians.
    Skjelbo E; Mutabingwa TK; Bygbjerg Ib; Nielsen KK; Gram LF; Brøosen K
    Clin Pharmacol Ther; 1996 Mar; 59(3):304-11. PubMed ID: 8653993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travelers: results of an international, randomized, open-label study.
    Camus D; Djossou F; Schilthuis HJ; Høgh B; Dutoit E; Malvy D; Roskell NS; Hedgley C; De Boever EH; Miller GB;
    Clin Infect Dis; 2004 Jun; 38(12):1716-23. PubMed ID: 15227617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proguanil, the isolation of a metabolite with high antimalarial activity.
    CROWTHER AF; LEVI AA
    Br J Pharmacol Chemother; 1953 Mar; 8(1):93-7. PubMed ID: 13066702
    [No Abstract]   [Full Text] [Related]  

  • 16. Malaria chemoprophylaxis regimens: a descriptive drug utilization study.
    Bloechliger M; Schlagenhauf P; Toovey S; Schnetzler G; Tatt I; Tomianovic D; Jick SS; Meier CR
    Travel Med Infect Dis; 2014; 12(6 Pt B):718-25. PubMed ID: 24934849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atovaquone-proguanil compared with chloroquine and chloroquine-sulfadoxine-pyrimethamine for treatment of acute Plasmodium falciparum malaria in the Philippines.
    Bustos DG; Canfield CJ; Canete-Miguel E; Hutchinson DB
    J Infect Dis; 1999 Jun; 179(6):1587-90. PubMed ID: 10228090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
    McKeage K; Scott L
    Drugs; 2003; 63(6):597-623. PubMed ID: 12656656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimalarial activities of triazine metabolites of chlorguanide and dichlorguanide.
    SCHMIDT LH; LOO TL; FRADKIN R; HUGHES HB
    Proc Soc Exp Biol Med; 1952 Jun; 80(2):367-70. PubMed ID: 14949053
    [No Abstract]   [Full Text] [Related]  

  • 20. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.
    Overbosch D; Schilthuis H; Bienzle U; Behrens RH; Kain KC; Clarke PD; Toovey S; Knobloch J; Nothdurft HD; Shaw D; Roskell NS; Chulay JD;
    Clin Infect Dis; 2001 Oct; 33(7):1015-21. PubMed ID: 11528574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.